Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
DOI
PMC
 |
Free by publisher |
Open Access Green as soon as Postprint is submitted to ZB.
Considering personalized Interferon-β therapy for COVID-19.
Antimicrob. Agents Chemother. 65:e00065-21 (2021)
Publ. Version/Full Text
DOI
PMC
Davoudi-Monfared et al. (1) report in this Journal the results from a clinical trial on COVID-19 patients showing that subcutaneous administration of interferon-β (IFN-β) was associated with a more rapid recovery from SARS-CoV-2 infection and decreased mortality.….
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Biotherapy ; Covid-19 ; Interferon Beta
ISSN (print) / ISBN
0066-4804
e-ISSN
1098-6596
Quellenangaben
Volume: 65,
Issue: 4,
Article Number: e00065-21
Publisher
American Society for Microbiology (ASM)
Publishing Place
1752 N St Nw, Washington, Dc 20036-2904 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Environmental Medicine (IEM)